## Interpretation of HBV Serology Markers **Key Point:** The combination of HBsAg positivity with anti-HBc IgM positivity is pathognomonic for acute hepatitis B infection. ### Serological Profile Analysis | Marker | Result | Significance | |--------|--------|---------------| | HBsAg | Positive | Indicates active infection (acute or chronic) | | Anti-HBc IgM | Positive | **Diagnostic of acute infection** — appears early, peaks at 1–2 months, disappears by 6 months | | Anti-HBc IgG | Negative | Would be present in chronic infection or past exposure | | HBeAg | Positive | Indicates high viral replication and infectivity | | Anti-HBe | Negative | Confirms active replication phase | ### Clinical Context **High-Yield:** The needle-stick injury 6 months ago is the exposure window. Acute HBV has an incubation period of 45–180 days (average 60–90 days), making this timeline consistent. **Clinical Pearl:** Anti-HBc IgM is the **earliest and most specific marker** of acute HBV infection. It appears before jaundice and disappears within 6 months. Its presence definitively excludes chronic infection or past resolved infection. ### Why This Is Acute, Not Chronic 1. **Anti-HBc IgM is positive** — this marker is virtually absent in chronic HBV 2. **Clinical presentation** — acute onset with jaundice and elevated transaminases (>1000 IU/L) 3. **Timeline** — 6 months post-exposure fits the incubation period 4. **Preserved synthetic function** — albumin 3.8 g/dL suggests compensated acute hepatitis, not cirrhosis **Mnemonic — Acute vs. Chronic HBV:** **"IgM = Acute"** — if anti-HBc IgM is positive, think acute. If anti-HBc IgG is positive (without IgM), think chronic or resolved. ## Management Implications - Supportive care; most adults clear acute HBV spontaneously - Monitor for fulminant hepatic failure (PT/INR, bilirubin trends) - Counsel on transmission prevention - Repeat serology at 6 months to confirm clearance (HBsAg should become negative)
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.